Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Case report

Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report

Authors: Keiji Sugai, Hiroyuki Ueda, Keita Morimoto, Mai Tanaka, Daisuke Takahashi, Akio Nakashima, Junichiro Kato, Hiroshi Takahashi, Yutaka Yamaguchi, Tetsuya Kawamura, Kazushige Hanaoka, Yoichi Miyazaki, Takashi Yokoo

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Maternally inherited diabetes and deafness (MIDD), a mitochondrial genetic disorder, typically affects the kidneys and results in end-stage renal disease. Early diagnosis of MIDD is challenging when renal manifestations precede other key clinical features such as diabetes and deafness and/or when the disease is complicated by other renal pathologies.

Case presentation

Here, we present the case of a 33-year-old Japanese woman who had initially been diagnosed with IgA nephropathy but was found to have MIDD 6 years later. Two renal biopsies were conducted six years apart. While assessment of the first biopsy specimen with the monoclonal antibody (KM55) revealed mesangial IgA deposits (containing the galactose-deficient IgA1 variant [Gd-IgA1]), examination of the second specimen showed no mesangial IgA deposits and newly-developed glomerular global scleroses and tubular damage. Granular swollen epithelial cells (GSECs), characterised by abnormal mitochondria, were observed among the tubules and collecting ducts in both biopsy specimens. Mitochondrial DNA analysis revealed an m.3243A > G mutation.

Conclusions

We rediscovered the usefulness of GSECs as a pathologically distinctive feature of mitochondrial nephropathy and reviewed the literature regarding MIDD complicated by mesangial IgA deposition. Furthermore, we demonstrate that the mesangial IgA deposits in this patient consisted of the galactose-deficient IgA1 variant. The monoclonal antibody (KM55) might be a useful tool to distinguish IgAN from latent IgA deposits.
Literature
2.
17.
go back to reference Jennette JC, D'Agati VD, Olson JL, Silva MD, editors. Heptinstall's pathology of the kidney. 7th ed. Philadelphia: Wolters Kluwer; 2015. Jennette JC, D'Agati VD, Olson JL, Silva MD, editors. Heptinstall's pathology of the kidney. 7th ed. Philadelphia: Wolters Kluwer; 2015.
18.
go back to reference Cuevas X, Lloveras J, Mir M, Aubia J, Masramon J. Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation. Transplant Proc. 1987;19:2208–9. Cuevas X, Lloveras J, Mir M, Aubia J, Masramon J. Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation. Transplant Proc. 1987;19:2208–9.
20.
30.
32.
go back to reference Sanfilippo F, Croker BP, Bollinger RR. Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation. 1982;33:370–6.CrossRefPubMed Sanfilippo F, Croker BP, Bollinger RR. Fate of four cadaveric donor renal allografts with mesangial IgA deposits. Transplantation. 1982;33:370–6.CrossRefPubMed
Metadata
Title
Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report
Authors
Keiji Sugai
Hiroyuki Ueda
Keita Morimoto
Mai Tanaka
Daisuke Takahashi
Akio Nakashima
Junichiro Kato
Hiroshi Takahashi
Yutaka Yamaguchi
Tetsuya Kawamura
Kazushige Hanaoka
Yoichi Miyazaki
Takashi Yokoo
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-1152-6

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.